Abstract: A method of reducing the formaldehyde emission of a mineral fiber product bonded with a urea-modified phenol-formaldehyde resol resin-type binder comprises adding dextrose to the binder composition during and/or after preparation of the binder composition but before curing of the binder composition applied to the mineral fibers.

Abstract: Described is an aqueous binder composition for mineral fibers which comprises a component (i) in the form of one or more carbohydrates and a component (ii) in the form of one or more compounds selected from sulfamic acid, derivatives of sulfamic acid, salts thereof.

Abstract: The invention relates to an aqueous binder composition for mineral fibers comprising a component (i) in the form of one or more compounds selected from —compounds of the formula, and any salts thereof. In which R1 corresponds to H, alkyl, monohydroxyalkyl, dihydroxyalkyl, polyhydroxyalkyl, alkylene, alkoxy, amine; —compounds of the formula, and any salts thereof. In which R2 corresponds to H, alkyl, monohydroxyalkyl, dihydroxyalkyl, polyhydroxyalkyl, alkylene, alkoxy, amine; a component (ii) in the form of one or more compounds selected from the group of ammonia, amines or any salts thereof; a component (iii) in the form of one or more carbohydrates.

Abstract: The present invention relates to a mineral wool product comprising mineral fibres bound by a cured formaldehyde-free binder, wherein the binder in its uncured state comprises carbohydrate in a content of 70 to 97 wt. % of the total binder component solids; the mineral wool product has an unaged delamination strength of 20 kPa or more; the mineral wool product has a ratio between the aged delamination strength and the unaged delamination strength of more than 40%.

Abstract: An acoustical ceiling panel is provided having a core with a front face and a back face composed of air laid mineral fibers and an aqueous binder. The aqueous binder includes a first component in the form of one or more carbohydrates, and a second component in the form of one or more compounds selected from sulfamic acid, derivatives of sulfamic acid, and any salts thereof, ammonia and hypophosphorous acid. A formaldehyde-free first fleece having a thickness is secured to the front face of the core by powdered adhesive and a formaldehyde-free second fleece having a thickness is secured to the back face of the core by the aqueous binder, with the thickness of the first fleece being greater than the thickness of the second fleece. Paint is applied to the first fleece. The acoustical ceiling panel has formaldehyde emissions of below 8 ?g/m2/h of formaldehyde, preferably below 5 ?g/m2/h, most preferably below 3 ?g/m2/h, in accordance with ISO 16000 for testing aldehyde emissions.

Abstract: The invention relates to an aqueous binder composition for mineral fibers comprising a component (i) in the form of one or more compounds selected from—compounds of the formula, and any salts thereof. In which R1 corresponds to H, alkyl, monohydroxyalkyl, dihydroxyalkyl, polyhydroxyalkyl, alkylene, alkoxy, amine; —compounds of the formula, and any salts thereof. In which R2 corresponds to H, alkyl, monohydroxyalkyl, dihydroxyalkyl, polyhydroxyalkyl, alkylene, alkoxy, amine; a component (ii) in the form of one or more compounds selected from the group of ammonia, amines or any salts thereof; a component (iii) in the form of one or more carbohydrates.

Abstract: The invention provides a method of growing plants in a mineral wool growth substrate, the method comprising: providing at least one mineral wool growth substrate comprising man-made vitreous fibers bonded with a cured binder composition, and positioning one or more seeds or plants for growth in the growth substrate, and allowing growth of the one or more plants, wherein the binder composition prior to curing comprises: a) a sugar component, and b) a reaction product of a polycarboxylic acid component and an alkanolamine component, wherein the binder composition prior to curing contains at least 42% by weight of the sugar component based on the total weight (dry matter) of the binder components.

Abstract: Described is an aqueous binder composition for mineral fibers comprising a component (i) in the form of one or more compounds selected from compounds of the formulae set forth in the claims, and any salts thereof; a component (ii) in the form of one or more compounds selected from the group of ammonia, amines or any salts thereof; a component (iii) in the form of one or more carbohydrates; a component (iv) in the form of one or more compounds selected from sulfamic acid, derivatives of sulfamic acid or any salt thereof.

Abstract: Described is an aqueous binder composition for mineral fibers which comprises a component (i) in the form of one or more carbohydrates and a component (ii) in the form of one or more compounds selected from sulfamic acid, derivatives of sulfamic acid, salts thereof.

Abstract: An aqueous binder composition comprises: (1) a water-soluble binder component obtainable by reacting at least one alkanolamine with at least one polycarboxylic acid or anhydride and, optionally, treating the reaction product with a base; (2) a soy protein product; and, optionally, one or more of the following binder components; (3) a sugar component; (4) urea. The binder composition is particularly suitable as a binder for mineral fibres or as an adhesive for particle board and other composites.

Abstract: An aqueous binder composition for mineral fibres comprises: (1) a water-soluble binder component obtainable by reacting at least one alkanolamine with at least one polycarboxylic acid or anhydride and, optionally, treating the reaction product with a base; (2) a sugar component; and (3) urea, the proportion of components (1), (2) and (3) being within the range of 10 to 80 wt. % of (1), 15 to 80 wt. % of (2), and 5 to 60 wt. % of (3), based on the solids content of components (1), (2) and (3) as measured after heat treatment for 1 hour at 200° C.

Abstract: A method of reducing the formaldehyde emission of a mineral fibre product bonded with a urea-modified phenol-formaldehyde resol resin-type binder comprises the step of adding dextrose to the binder composition during and/or after preparation of the binder composition but before curing of the binder composition applied to the mineral fibres.

Abstract: The invention provides a method of growing plants in a mineral wool growth substrate, the method comprising: providing at least one mineral wool growth substrate comprising man-made vitreous fibres bonded with a cured binder composition, and positioning one or more seeds or plants for growth in the growth substrate, and allowing growth of the one or more plants, wherein the binder composition prior to curing comprises: a) a sugar component, and b) a reaction product of a polycarboxylic acid component and an alkanolamine component, wherein the binder composition prior to curing contains at least 42% by weight of the sugar component based on the total weight (dry matter) of the binder components.

Abstract: A bonded mineral fibre product exhibiting high fire resistance in accordance with Class A1 of Standard EN 13501-1 as well as improved punking resistance comprises man-made vitreous fibres (MMVF)) bound by a cured binder composition, the non-cured binder composition comprising (a) a sugar component, and either (b) a polycarboxylic acid component and an alkanolamine, or (c) a reaction product of a polycarboxylic acid component and an alkanolamine, or (d) a combination of (b) and (c), the amount of sugar component (a) being within the range of 42 to 72 percent by weight, based on the total weight (dry matter) of the binder components.

Abstract: Benzothiazine compounds of the general formula (I) and pharmaceutically acceptable salts or esters thereof are peptide deformylase inhibitors useful in the treatment or prevention of infections and other diseases in which peptide deformylases are involved, especially in the treatment of bacterial and parasitic infections, for example infections fully or partly caused by microorganisms belonging to Staphylococcus, Enterococcus, Streptococcus, Haemophilus, Moraxella, Escherichia, Mycobacterium, Mycoplasma, Pseudomonas, Chlamydia, Rickettsia, Klebsiella, Shigella, Salmonella, Bordetella, Clostridium, Helicobacter, Campylobacter, Legionella or Neisseria.

Abstract: A monoacyl semicarbazide of the general formula (I): (I), or a pharmaceutically acceptable salt or ester thereof, is capable of selectively inhibiting dipeptidyl-peptidase I (DPP-I), also known as cathepsin C. A compound of the invention is useful as an active substance for the treatment of inflammation, type 2 diabetes, asthma, severe influenza, respiratory syncytial virus infection, CD8 T cell inhibition, inflammsatory bowel diseases, psoriasis, atopic dermatitis, Papillon Lefevre syndrome, Haim Munik syndrome, gum disease, periodontitis, rheumatoid arthritis, Huntington's disease, Chaga's disease, Alzheimer's disease, sepsis or for application in target cell apoptosis.

Abstract: A peptidyl nitrile of the general formula (I) or a pharmaceutically acceptable salt or prodrug thereof, is capable of selectively inhibiting dipeptidyl-peptidase (DPP-I), also known as cathepsin C. A compound of the invention is useful as an active substance for the treatment of inflammation, type 2 diabetes, asthma, severe influenza, respiratory syncytial virus infection, CD8 T cell inhibition, inflammatory bowel diseases, psoriasis, atopic dermatitis, Papillon Lefevre syndrome, Haim Munk syndrome, gun disease, periodontitis, rheumatoid arthritis, Huntington's disease, Chagas' disease, Alzheimer's disease, sepsis or for application in target cell apoptosis.

Abstract: Benzimidazole compounds of the general formula (I) and pharmaceutically acceptable salts or esters thereof are peptide deformylase inhibitors useful in the treatment or prevention of infections and other diseases in which peptide deformylases are involved, especially in the treatment of bacterial and parasitic infections, for example infections fully or partly caused by microorganisms belonging to Staphylococcus, Enterococcus, Streptococcus, Haemophilus, Moraxella, Escherichia, Mycobacterium, Mycoplasma, Pseudomonas, Chlamydia, Rickettsia, Klebsiella, Shigella, Salmonella, Bordetella, Clostridium, helicobacter, Campylobacter, Legionella, or Neisseria.

Abstract: Isoxazole compounds of formula (I) and pharmaceutically acceptable salts or esters thereof are peptide deformylase inhibitors useful in the treatment or prevention of infections and other disease in which peptide deformylases are involved, especially in the treatment of bacterial and parasitic infections, for example infections fully or partly caused by microorganisms belonging to Staphylococcus, Enterococcus, Streptococcus, Haemophilus, Moraxella, Escherichia, Mycobacterium, Mycoplasma, Pseudomonas, Chlamydia, Rickettsia, Klebsiella, Shigella, Salmonella, Bordetella, Clostridium, Helicobacter, Campylobacter, Legionella or Neisseria.

Abstract: Non-peptide compounds comprising a central hydrazide motif and methods for the synthesis thereof are disclosed. The compounds act to antagonize the action of the glucagon peptide hormone.